Author

Ahmed ElZoghby

Instructor of Medicine, Harvard Medical School, Brigham & Women's Hospital, Engineering in Medicine - Cited by 6,907 - Immunoengineering - Biomedical Engineering - Cancer Nanomedicine - Drug Delivery - Cancer Immunotherapy

Biography

Ahmed Elzoghby currently works as a postdoctoral research fellow at division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Ahmed research in the field of biomedical engineering tries to address medical problems such as cancer metastasis with an engineering approach.
Title
Cited by
Year
Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand
AO Elzoghby, MA Abdelmoneem, IA Hassanin, MM Abd Elwakil, ...Biomaterials 263, 120355, 2020202
92
2020
Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy
OM Ali, AA Bekhit, SN Khattab, MW Helmy, YS Abdel-Ghany, M Teleb, ...Colloids and Surfaces B: Biointerfaces 188, 110824, 2020202
72
2020
Liquid crystalline assembly for potential combinatorial chemo–herbal drug delivery to lung cancer cells
HM Abdelaziz, AO Elzoghby, MW Helmy, MW Samaha, JY Fang, ...International journal of nanomedicine, 499-517, 2019201
57
2019
Dual-targeted lactoferrin shell-oily core nanocapsules for synergistic targeted/herbal therapy of hepatocellular carcinoma
MA Abdelmoneem, MA Elnaggar, RS Hammady, SM Kamel, MW Helmy, ...ACS applied materials & interfaces 11 (30), 26731-26744, 2019201
50
2019
Albumin-based nanoparticles: A promising strategy to overcome cancer drug resistance
I Hassanin, A ElzoghbyCancer Drug Resistance 3 (4), 930, 2020202
49
2020
Magnetically guided self-assembled protein micelles for enhanced delivery of dasatinib to human triple-negative breast cancer cells
SA Sabra, SA Sheweita, M Haroun, D Ragab, MA Eldemellawy, Y Xia, ...Journal of pharmaceutical sciences 108 (5), 1713-1725, 2019201
48
2019
Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging
DG Zayed, AS AbdElhamid, MS Freag, AO ElzoghbyNanomedicine 14 (3), 225-228, 2019201
42
2019
Lactoferrin-dual drug nanoconjugate: Synergistic anti-tumor efficacy of docetaxel and the NF-κB inhibitor celastrol
MA Abdelmoneem, MM Abd Elwakil, SN Khattab, MW Helmy, AA Bekhit, ...Materials Science and Engineering: C 118, 111422, 2021202
35
2021
Inhalable dual-targeted hybrid lipid nanocore–protein shell composites for combined delivery of genistein and all-trans retinoic acid to lung cancer cells
NM Kamel, MW Helmy, EZ Abdelfattah, SN Khattab, D Ragab, ...ACS Biomaterials Science & Engineering 6 (1), 71-87, 2019201
34
2019
Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin–QDs nano-hybrids: covalent coupling and phospholipid complexation approaches
DG Zayed, SM Ebrahim, MW Helmy, SN Khattab, M Bahey-El-Din, ...Journal of Nanobiotechnology 17 (1), 1-19, 2019201
34
2019
Inhalable lactoferrin/chondroitin-functionalized monoolein nanocomposites for localized lung cancer targeting
HM Abdelaziz, AO Elzoghby, MW Helmy, EZA Abdelfattah, JY Fang, ...ACS Biomaterials Science & Engineering 6 (2), 1030-1042, 2020202
31
2020
A novel ‘smart’PNIPAM-based copolymer for breast cancer targeted therapy: Synthesis, and characterization of dual pH/temperature-responsive lactoferrin-targeted PNIPAM-co-AA
ORM Metawea, MA Abdelmoneem, NS Haiba, HH Khalil, M Teleb, ...Colloids and Surfaces B: Biointerfaces 202, 111694, 2021202
30
2021
Promoted antitumor activity of myricetin against lung carcinoma via nanoencapsulated phospholipid complex in respirable microparticles
N Nafee, DM Gaber, AO Elzoghby, MW Helmy, OY AbdallahPharmaceutical Research 37, 1-24, 2020202
29
2020
Oleic acid-based nanosystems for mitigating acute respiratory distress syndrome in mice through neutrophil suppression: how the particulate size affects therapeutic efficiency
HP Yu, FC Liu, A Umoro, ZC Lin, AO Elzoghby, TL Hwang, JY FangJournal of nanobiotechnology 18, 1-16, 2020202
25
2020
Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs
IA Hassanin, AO ElzoghbyExpert Opinion on Drug Delivery 17 (10), 1437-1458, 2020202
24
2020
Co-administration of tretinoin enhances the anti-cancer efficacy of etoposide via tumor-targeted green nano-micelles
M Gaber, KA Elhasany, S Sabra, MW Helmy, JY Fang, SN Khattab, ...Colloids and Surfaces B: Biointerfaces 192, 110997, 2020202
22
2020
Boronic-targeted albumin-shell oily-core nanocapsules for synergistic aromatase inhibitor/herbal breast cancer therapy
M Gaber, M Hany, S Mokhtar, MW Helmy, KA Elkodairy, AO ElzoghbyMaterials Science and Engineering: C 105, 110099, 191
20
2019
Nanomedicine-based approaches for improved delivery of phyto-therapeutics for cancer therapy
DA Hafez, KA Elkhodairy, M Teleb, AO ElzoghbyExpert opinion on drug delivery 17 (3), 279-285, 2020202
18
2020
Recent advances in herbal combination nanomedicine for cancer: delivery technology and therapeutic outcomes
DM Anwar, M El-Sayed, A Reda, JY Fang, SN Khattab, AO ElzoghbyExpert opinion on drug delivery (11), 1609-1625, 2021202
18
2021
Combination of magnetic targeting with synergistic inhibition of NF-κB and glutathione via micellar drug nanomedicine enhances its anti-tumor efficacy
KA Elhasany, SN Khattab, AA Bekhit, DM Ragab, MA Abdulkader, A Zaky, ...European Journal of Pharmaceutics and Biopharmaceutics 155, 162-176, 2020202
18
2020

Referred From: https://scholar.google.com.eg/citations?user=TsIbm6UAAAAJ&hl=en

Cited by
Citations 6907
h-index 40
i10-index 73
Open Access Journals